Clinical Trial Update: Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of Trenev Trio/Healthy Trinity for diarrhea-predominant irritable bowel syndrome and functional dyspepsia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Irritable Bowel Syndrome

Drugs mentioned

• Healthy Trinity
• Trenev Trio

Snippet

Sponsor: Sprim Advanced Life Sciences | Conditions: IBS-D and Functional Dyspepsia | Phase 2, Phase 3 | Status: TERMINATED